跳至主要内容
临床试验/NL-OMON28309
NL-OMON28309已完成不适用

A randomised, double blind, parallel, placebo controlled, drug-drug interaction study to investigate the safety, tolerability and pharmacokinetics of multiple doses of HTL0018318 given alone and in combination with donepezil at steady state in elderly volunteers.

Heptares Therapeutics Ltd.0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36

研究概览

简要总结

ot applicable

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Elderly male or female subjects aged between 65 and 80 (inclusive) years old;
  • 2. Healthy subjects as defined by the absence of evidence of any active or chronic disease following detailed medical and surgical history review and a complete physical examination including vital signs, 12-lead ECG, haematology, blood chemistry, and urinalysis;

排除标准

  • Subjects must meet none of the following exclusion criteria at screening:
  • 1. Legal incapacity or inability to understand or comply with the requirements of the study.

研究者

发起方
Heptares Therapeutics Ltd.

相似试验